Friday, May 1, 2026

Revolutionizing Drug Development: Ewha Womans University Partners with Cureverse for AI-Powered Innovations

Ewha Womans University and Cureverse Inc. partner for AI-driven drug development, focusing on collaboration and expert training.

Korea’s Biotech Healthcare Firms Possess Cutting-edge AI Diagnostics and Precision Medicine

South Korea's biotech sector excels in technology but needs better storytelling and governance to attract global investments.

Ministry of Unification Vice Minister Kim Nam Jung Meets UN Rapporteur Elizabeth Salmon: Linking Peace Policy to North Korea Human Rights

Vice Minister Kim discusses inter-Korean exchanges and human rights with UN Rapporteur Salmon, aiming for peace and improved lives in North Korea.

Tag: production

Discover the Breakthroughs of Korea’s ARPA-H Project at BIO KOREA 2026!

The K-Health Future Promotion Team will unveil interim results of the Korean-style ARPA-H project at BIO KOREA 2026, addressing healthcare challenges.

$75M Bet on Next-Gen Chips: Hanmi Unveils Hybrid Bonder for HBM

Hanmi Semiconductor will launch a 2nd Gen Hybrid Bonder for HBM production and invest $75M in a new factory to meet rising demand.

Revolutionary Male Contraceptive: New Method Halts Sperm Production Without Hormonal Side Effects

A Cornell team developed a reversible male contraceptive, blocking sperm production without hormonal side effects, using a compound called JQ1.

South Korea Government Response: Quick Solutions to Naphtha Supply Issues for Medical Materials

South Korea's government is expediting approvals for medical supply production amid naphtha supply issues, easing industry concerns.

How KAIST’s Quinone-Titanium Catalyst Could Transform Energy Production in 2026

A KAIST research team developed a stable molecular catalyst combining quinone and titanium, enhancing artificial energy production methods.

Celltrion’s 1 Trillion KRW Investment: A Game Changer for Biopharmaceutical Production by 2030

Celltrion plans a major expansion with over 1 trillion KRW investment, boosting production capacity for biosimilars and new drugs by 2030.

Estipam Secures Record 897 Billion KRW Contract for Oligonucleotide Raw Materials: What This Means for the Asian Market

ST Pharm secures a record 89.7 billion KRW contract for oligonucleotide ingredients, enhancing its global market position.

China Set to Overtake South Korea in OLED Production by 2029

China's OLED production is set to surpass South Korea's by 2029, driven by aggressive investments and growth in display technology.

Samsung Biologics CEO John Rim Poised for Third Term: What This Means for the Global CDMO Market in 2026

John Rim of Samsung Biologics aims for a third term, leading record growth and expansion into next-gen therapies amid global challenges.

CGBio’s NovoFactory: A Game-Changer for Bone Graft Products in the U.S. and Japan

CGBio's new Novo Factory in Hwaseong receives approval to produce Novosis Putty, targeting advanced markets like the U.S. and Japan.

Samsung Biologics: How a 56 Billion USD CDMO Leader is Shaping the Future of Biopharmaceuticals

Samsung Biologics is evolving as a leading CDMO, targeting a production capacity of 1.32M liters by 2030 after its spin-off from Bioepis.

Hyderabad’s New CKD Production Line: How Huons Meditech and Vasu Group are Revolutionizing Endoscope Sterilizers in India

Huons Meditech inaugurated a CKD production line for endoscope disinfectors in India, enhancing local production and market expansion.

Samsung Biologics Partners with CEPI: A Game-Changer for Global Vaccine Production

Samsung Biologics partners with CEPI to enhance vaccine production for pandemics, aiming for rapid global supply and health security.

Samsung Biologics Unveils Three-Pillar Growth Strategy: How Capacity, Portfolio, and Global Expansion Shape 2026

Samsung Biologics outlines a growth strategy focused on production, portfolio, and global expansion to enhance its CDMO position.

Top News

- Our Sponsors Ad -

Follow us